ABERA BIOSCIENCE AB Financial Flexibility Index
ABERA BIOSCIENCE AB financial flexibility index. ABERA BIOSCIENCE AB (8WK) has a Financial Flexibility Index of -0.98x as of March 2026. Free cash flow of €-7.44 Million (operating CF €-7.44 Million minus capex €0.00) represents -1% of total liabilities (€7.57 Million). See free cash flow generation of ABERA BIOSCIENCE AB to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ABERA BIOSCIENCE AB (2022–2025)
Financial flexibility index of ABERA BIOSCIENCE AB from 2022 to 2025. Historical Financial Flexibility Index trend for ABERA BIOSCIENCE AB across 4 annual periods. Check ABERA BIOSCIENCE AB (8WK) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
ABERA BIOSCIENCE AB Financial Flexibility Index by Year (2022–2025)
ABERA BIOSCIENCE AB financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for ABERA BIOSCIENCE AB. For the full cash flow conversion analysis, see ABERA BIOSCIENCE AB (8WK) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.31x | €-2.83 Million | €-3.26 Million | €9.28 Million | ▼ -261.8% |
| 2024 | 0.19x | €933.00K | €-198.00K | €4.95 Million | ▲ +103.9% |
| 2023 | -4.80x | €-17.71 Million | €-17.71 Million | €3.69 Million | ▲ +31.9% |
| 2022 | -7.05x | €-19.69 Million | €-19.69 Million | €2.80 Million | — |